Bromosporine inhibits various bromodomains including BRD2, BRD4, BRD9 and CECR2 with IC50s of 0.41 μM, 0.29 μM, 0.122 μM and 0.017 μM respectively.

UNC1215 is a chemical probe for the methyllysine (Kme) reader domain of L3MBTL3 with Kd of 120 nM.

UNC 669是L3MBTL1和L3MBTL3的甲基赖氨酸结合结构域的配体，其抑制L3MBTL1和L3MBTL3的IC50值分别为4.2 μM和3.1 μM。

BAZ1A-IN-1是一种针对 BAZ1A 的有效抑制剂，具有较高的选择性和特异性。它在 BAZ1A 高表达的癌细胞中表现出显著的抑制活性，适用于癌症治疗研究。

UNC6852 是基于 PROTAC 技术的选择性 PRC2 降解剂。它包含一个 EED 配体和一个 Von Hippel-Lindau 配体，对 EED 的 IC50 值为 247 nM。

666-15是一种高效且选择性的CREB抑制剂，IC50为81 nM，在乳腺癌异种移植模型中抑制肿瘤生长。

UNC 926 HCl binds to MBT domain of L3MBTL protein (Kd = 3.9 µM) and block the interaction with methylated lysine on histone 4, H4K20.

EED226 is a potent and selective PRC2 inhibitor that directly binds to the H3K27me3 binding pocket of EED.

PFI-3 is a potent and selective polybromo 1 and SMARCA4 inhibitor (Kd values are 48 and 89 nM respectively).

GSK2801 inhibits BAZ2 family of bromodomain-containing proteins BAZ2A (Kd = 260 nM) and BAZ2B (Kd= 140 nM, IC50 = 9-350 nM).

KG-501 is histochemical substrate of alkaline phosphatases and can inhibit CREB-CBP interaction.

BI-9564 is an inhibitor of BRD9 (IC50 = 75 nM) and BRD7 (IC50 = 3.4 µM).

BRD9539 inhibits G9a activity with an IC50 of 6.3 μM, inhibits PRC2 activity with a similar IC50.